Table 1.
Patient characteristics
| Pt # | ATLL Subtype | Stage | Wbc | CD3 | CD4 | CD25 | LDH | Ca | BM | PVL |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Acute | IV | 135.7 | 119 | 119 | 67 | 550 | 14.1 | 81% | 145.4 |
| 2 | Acute | IV | 20.6 | 6.3 | 6.4 | 5.9 | 1,269 | 10.1 | 59% | 77.3 |
| 3 | Acute | IV | 69.4 | 65.2 | 63.1 | nd | 1,496 | 9 | nd | 88.4 |
ATLL subtype, Shimoyama classification; BM, bone marrow % malignant cell; Ca, calcium (mg/dL, 8.5–9.9 normal); CD3, CD4 or CD25 (K/cumm); LDH, lactate dehydrogenase (U/L, normal <250); nd, not determined; PVL, proviral load (copies/100 PBMCs); stage, Ann Arbor lymphoma stage; wbc, white blood cell count (K/cumm).